Trump seeks to squeeze drugmakers’ revenues to pay for tax cuts

The small island became Europe's largest pharmaceutical exporter to the USA with a smart location policy. American corporations have invested many billions. But the US President wants to bring the factories back to their home country.

Trump seeks to squeeze drugmakers’ revenues to pay for tax cuts

By Rachel Cohrs Zhang, Bloomberg News President Donald Trump has set his sights on the pharmaceutical industry to shoulder part of the cost of his tax cuts, pressing congressional Republicans to force drugmakers to accept lower prices on prescriptions covered by Medicaid. Trump asked House Republicans to mandate the government health program for low-income and disabled Americans get the lowest price for drugs that certain foreign countries are c…

President Donald Trump has in sight an industry that will have to pay the cost of tax cuts.The president pressures Republicans in Congress to force drug manufacturers to accept the lowest prices for prescriptions covered by Medicaid, the public health insurance program for some individuals and families with scarce income and resources.Trump asked Republicans in the House of Representatives to make the government health program have lower prices …

SEAN SPICER: Medication Can Be Affordable — Even Without Taxpayers Footing The Bill

The Trump administration is doubling down on its commitment to responsible federal spending.

Trump Seeks to Squeeze Drugmakers’ Revenues to Pay for Tax Cuts

President Donald Trump has set his sights on the pharmaceutical industry to shoulder part of the cost of his tax cuts, pressing congressional Republicans to force drugmakers to accept lower prices on prescriptions covered by Medicaid.

Lowering Drug Costs: What Employers Need to Know from the Latest Executive Order

Quick Look New Executive Order (EO) on drug prices aimed at reducing prescription drug costs through increased transparency, PBM reform, and enhanced competition. The EO mandates agencies to evaluate and regulate PBMs, requiring greater transparency in their compensation and role in drug pricing. The EO reinforces requirements for health plans to disclose actual drug prices and outlines new enforcement measures. On April 15, 2025, President Tru…